GMRE-PA:NYE-Global Medical REIT Inc (USD)

PREFERRED STOCK | REIT - Healthcare Facilities |

Last Closing

USD 25.5806

Change

-0.32 (-1.23)%

Market Cap

USD 0.41B

Volume

2.36K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Global Medical REIT Inc. (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

+0.21 (+0.16%)

USD 79.04B
VTR Ventas Inc

-0.22 (-0.34%)

USD 26.84B
DOC Healthpeak Properties Inc

+0.18 (+0.82%)

USD 15.67B
CTRE CareTrust REIT Inc.

-0.06 (-0.19%)

USD 4.79B
NHI National Health Investors Inc

+0.41 (+0.48%)

USD 3.63B
AHR American Healthcare REIT, Inc.

+0.22 (+0.90%)

USD 3.23B
LTC LTC Properties Inc

+0.04 (+0.11%)

USD 1.64B
UHT Universal Health Realty Income..

+0.20 (+0.43%)

USD 0.64B
CHCT Community Healthcare Trust Inc

-0.11 (-0.63%)

USD 0.46B
GMRE Global Medical REIT Inc

-0.01 (-0.10%)

N/A

ETFs Containing GMRE-PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.36% 21% F 27% F
Dividend Return 5.52% 79% B- 84% B
Total Return 5.87% 21% F 37% F
Trailing 12 Months  
Capital Gain 1.47% 14% F 25% F
Dividend Return 7.44% 64% D 83% B
Total Return 8.91% 14% F 33% F
Trailing 5 Years  
Capital Gain -4.23% 62% D 40% F
Dividend Return 31.59% 77% C+ 85% B
Total Return 27.36% 69% C- 51% F
Average Annual (5 Year Horizon)  
Capital Gain -0.73% 64% D 33% F
Dividend Return 6.06% 64% D 51% F
Total Return 6.80% 86% B+ 88% B+
Risk Return Profile  
Volatility (Standard Deviation) 4.92% 100% F 91% A-
Risk Adjusted Return 123.29% 100% F 99% N/A
Market Capitalization 0.41B 10% F 45% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.